Clearing the Smoke on Cannabis: Cannabis Use and Driving – An Update
Presents the latest clinical evidence on cannabis use and impaired driving among Canadians.
Opioids (Canadian Drug Summary)
Summarizes data on the use of opioids, including the medical and nonmedical use, effects and legal status.
Standing Committee on Health: Canada’s Health Workforce Brief (Policy Brief)
A version of this document was submitted to the Standing Committee on Canada’s Health Workforce in May 2022.
Standing Committee on Health: Women’s Health Brief
Submitted to the Standing Committee on Health on Women’s Health in October 2022.
Submission for the Pre-Budget Consultations in Advance of the 2022–2023 Federal Budget
Submitted to the Standing Committee on Finance October 2022.
3-4 Methylenedioxy-methamphetamine (MDMA, Ecstasy or Molly) (Canadian Drug Summary)
Summarizes data on the use of 3-4 methylenedioxy-methamphetamine (MDMA, ecstasy or Molly), including the harms, effects and legal status.
Cocaine (Canadian Drug Summary)
Summarizes data on the use of cocaine, including the harms and effects, legal status and access to treatment. The prevalence of cocaine use was two per cent among people living in Canada in 2019.
Mental Health and Substance Use During COVID-19 [infographic]
Highlights key data from the Mental Health and Substance Use During COVID-19: Regional Spotlight and Key Factors final summary report.
